Pancreatic Cancer Research

ResearcherJiangsu UniversityActive in the last 2 years

Xiang Liao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-6847-8811; OpenAlex author ID A5113987126. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. Radiotherapy followed by metformin neoadjuvant therapy drives superior pancreatic cancer ferroptosis and augments anti-tumor immunity. Last author DOI 10.1016/j.fmre.2025.12.010↗
  2. Hallmarks of perineural invasion in pancreatic ductal adenocarcinoma: new biological dimensions. Co-author DOI 10.3389/fonc.2024.1421067↗
  3. KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression. Co-author DOI 10.3389/fcell.2023.1147676↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dongqing Wang · 2 shared papers, 2024–2026 · strength 0.58
  2. Yaquan Sun · 1 shared paper, 2024 · strength 0.31
  3. Xin Wang · 1 shared paper, 2026 · strength 0.27
  4. Wenjin Xu · 1 shared paper, 2026 · strength 0.27
  5. Haitao Zhu · 1 shared paper, 2026 · strength 0.27
  6. Zining Zhang · 1 shared paper, 2023 · strength 0.26
  7. Hsiang‐i Tsai · 1 shared paper, 2023 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.